Coronary Stents Market By Type, By Biomaterial, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

Coronary Stents Market By Type, By Biomaterial, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

  • March 2022 •
  • 236 pages •
  • Report ID: 6286339 •
  • Format: PDF
Coronary Stents Market By Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), By Biomaterial (Metallic biomaterials, Polymers biomaterials, Natural biomaterials), By End User (Hospitals, Ambulatory Surgical Centers, Other): Global Opportunity Analysis and Industry Forecast, 2020-2030

The global coronary stents market was valued at $8,814.9 million in 2020 and is projected to reach $15,421.06 million by 2030, registering a CAGR of 6.0% from 2021 to 2030.
Coronary stent is a  small expandable tube, which is used for the treatment of narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated using these stents. These stents are also known as cardiac stents and comprise metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI).
The factor that drives growth of coronary stents market include increase in incidence of CAD, rise in innovation in coronary stents, and surge in improved clinical outcomes, due to stenting.
In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity and improved insurance & reimbursement scenario supplement the global coronary stents market growth.
Conversely, availability of alternative methods for coronary heart disease treatment and high cost of treatment associated with coronary stents hinder the growth of the market during forecast years. However, increase in adoption of coronary stents in developing countries is expected to offer lucrative growth opportunities for the market during the forecast period.
The global coronary stents market is segmented on the basis of product, biomaterial, end user, and region. Depending on product, it is classified into drug-eluting stent, bare-metal stent, and bioabsorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. According to end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Becton Dickinson and Company, Microport Scientific Corporation, Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group, Ltd., and Elixir Medical Corporation.

Key Benefits For Stakeholders
?This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary stents market analysis from 2020 to 2030 to identify the prevailing coronary stents market opportunities.
?The market research is offered along with information related to key drivers, restraints, and opportunities.
?Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
?In-depth analysis of the coronary stents market segmentation assists to determine the prevailing market opportunities.
?Major countries in each region are mapped according to their revenue contribution to the global market.
?Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
?The report includes the analysis of the regional as well as global coronary stents market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type
? Drug-eluting Stents
? Bare-metal Coronary Stents
? Bioabsorbable Stents

By Biomaterial
? Metallic biomaterials
? Polymers biomaterials
? Natural biomaterials

By End User
? Hospitals
? Ambulatory Surgical Centers
? Other

By Region
? North America
? U.S.
? Canada
? Mexico
? Europe
? Germany
? France
? U.K.
? Italy
? Spain
? Rest of LAMEA
? Asia-Pacific
? China
? Japan
? India
? Australia
? South Korea
? Rest of LAMEA
? Brazil
? Saudi Arabia
? South Africa
? Rest of LAMEA
? Key Market Players
? Abbott Laboratories
? B. Braun Melsungen AG
? Biotronik Se & Co. KG
? Boston Scientific Corporation
? Becton, Dickinson and Company
? Elixir Medical Corporation
? Medtronic PLC.
? Microport Scientific Corporation
? Biosensors International Group
? Terumo Corporation